Average Co-Inventor Count = 4.40
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Washington (17 from 2,100 patents)
2. Vanderbilt University (3 from 1,153 patents)
3. Icos Corporation (3 from 164 patents)
4. University of Bern (2 from 17 patents)
5. Mount Sinai School of Medicine (1 from 242 patents)
6. Joseph A. Beavo (0 patent)
7. Ann Kadlecek (0 patent)
8. Kenneth M. Ferguson (0 patent)
9. Sharron H. Francis (0 patent)
10. Kate Loughney (0 patent)
11. Melissa K. Thomas (0 patent)
12. William K. Sonnenburg (0 patent)
13. Jackie D. Corbin (0 patent)
14. Linda M. Mcallister-lucas (0 patent)
17 patents:
1. 7842478 - DNA encoding mammalian phosphodiesterases
2. 7598067 - PDEs and uses thereof
3. 7179614 - Screening methods to identify compounds that modulate type I phosphodiesterase (PDE) activity
4. 7138259 - PDEs and uses thereof
5. 7122363 - DNA encoding mammalian phosphodiesterases
6. 6642040 - Human cGMP-stimulated cyclic nucleotide phosphodiesterase
7. 6037119 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and
8. 6015677 - Assay methods using DNA encoding mammalian phosphodiesterases
9. 5955583 - Antibodies to cGMP-binding, cGMP-specific phospodiesterase
10. 5800987 - Assay methods using DNA encoding mammalian phosphodiesterases
11. 5789553 - Antibodies specifically immunoreactive with human brain Ca.sup.2+
12. 5776752 - Isolated and purified calcium/calmodulin stimulated cyclic nucleotide
13. 5702936 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and
14. 5652131 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and
15. 5602019 - DNA encoding mammalian phosphodiesterases